The importance of sputum cytology in the diagnosis of lung cancer: A cost-effectiveness analysis

Chest

Volumn 112, Issue 4, 1997, Pages 937-945

  Raab, Stephen S ^a   Hornberger, John ^b   Raffin, Thomas ^b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cost effectiveness; Diagnostic testing; Pulmonary lesions

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BRONCHOSCOPY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; HEALTH CARE COST; HUMAN; LIFE EXPECTANCY; LUNG CANCER; MALE; MORTALITY; PRIORITY JOURNAL; SPUTUM CYTODIAGNOSIS; THORACOSCOPY;

EID: 0030756367     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.112.4.937     Document Type: Article

References (48)

1. American Cancer Society. Cancer facts and figures. Atlanta: American Cancer Society, 1995
2. Erozan V, Frost J. Cytopathologic diagnosis of cancer in pulmonary material: a critical histopathologic correlation. Acta Cytol 1970; 14:560-65
3. Johnston WW, Bossen EH. Ten years of respiratory cytopathology at Duke University Medical Center: II. The cytopathologic diagnosis of lung cancer during the years 1970-1974, noting the significance of specimen number and type. Acta Cytol 1981; 25:103-07
4. Johnston WW, Elson C. Cytology of other body sites: respiratory tract. In: Bibbo M, ed. Comprehensive cytopathology. Philadelphia: Saunders, 1991; 320-98
5. Mehta AC, Marty JJ, Lee FWY. Sputum cytology. Lung Cancer 1993; 14:36-85
6. Arroliga A, Matthay R. The role of bronchoscopy in lung cancer. Lung Cancer 1993; 14:87-98
7. Farber S, Benioff M, Frost J, et al. Cytologic studies of sputum and bronchial secretions in primary carcinoma of the lung. Dis Chest 1948; 14:633-64
8. Koss L, Melamed M, Goodner J. Pulmonary cytology: a brief survey of diagnostic results from July 1st, 1952 until December 31st, 1960. Acta Cytol 1964; 8:104-13
9. McDonald J. Pulmonary cytology. Am J Surg 1955; 89:462-64
10. Ng ABP, Horack GC. Factors significant in the diagnostic accuracy of lung cytology in bronchial washing and sputa samples: II. Sputum samples. Acta Cytol 1983; 27:397-402
11. Pilotti S, Rilke F, Gribandi G. Sputum cytology for the diagnosis of carcinoma of the lung. Acta Cytol 1982; 26: 649-54
12. Salazar A, Westcott J. The role of thoracic needle biopsy for the diagnosis and staging of lung cancer. Lung Cancer 1993; 14:99-110
13. Spjut H, Fier D, Ackerman L. Exfoliative cytology and pulmonary cancer. J Thorac Surg 1955; 30:90-107
14. Tanaka T, Yamamoto M, Tamura T, et al. Cytologic and histologic correlation in primary lung cancer: a study of 154 cases with resectable tumors. Acta Cytol 1985; 28:49-56
15. Umiker W. The role of exfoliative cytopathology in the routine diagnosis of bronchogenic carcinoma: a five year study of 152 consecutive, unrelated cases. Dis Chest 1961; 40:154-59
16. Garcia RF, Diaz Lobato S, Pino JM, et al. Value of CT-guided fine needle aspiration in solitary pulmonary nodules with negative fiberoptic bronchoscopy. Acta Radiol 1994; 35: 478-80
17. Harrow EM, Wang KP. The staging of lung cancer by bronchoscopic transbronchial needle aspiration. Chest Surg Clin North Am 1996; 6:223-35
18. Schenk DA, Chambers SL, Derdak S, et al. Comparison of the Wang 19-gange and 22-gange needles in the mediastinal staging of lung cancer. Am Rev Respir Dis 1993; 147:1251-58
19. Wang KP. Transbronchial needle aspiration and percutaneous needle aspiration for staging and diagnosis of lung cancer. Clin Chest Med 1995; 16:535-52
20. Castella J, Buj J, Puzo C, et al. Diagnosis and staging of bronchogenic carcinoma by transtracheal and transbronchial needle aspiration. Ann Oncol 1995; 6(suppl 3):S21-4
21. Chin R, Ward R, Keyes JW, et al. Mediastinal staging of non-small-cell lung cancer with positron emission tomography. Am J Respir Crit Care Med 1995; 152:2090-96
22. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with x-ray computed tomography. Eur J Nucl Med 1996; 23:741-77
23. National Cancer Institute, Health. Lung cancer surveillance, epidemiology and end results (SEER) program. Bethesda, Md: National Institutes of Health Press, 1994
24. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S-233S
25. Greenberg S, Fraire A, Kinner B, et al. Tumor cell type versus staging in the prognosis of carcinoma of the lung. Pathol Annu 1995; 2:398-405
26. Hoogstraten B. Lung tumors. Berlin: Springer-Verlag, 1988
27. Martini N. Operable lung cancer. CA Cancer J Clin 1993; 43:201-14
28. Shields T. Surgical therapy for carcinoma of the lung. Lung Cancer 1993; 14-47:121-47
29. National Center for Health Statistics, Public Health Service, Vital statistics of the United States, life tables (vol 2, section 6). Washington, DC: US Government Printing Office, 1986
30. Ginsberg R. Surgery and small cell lung cancer: an overview. Lung Cancer 1989; 5:232-36
31. DeMay RM. Respiratory cytology: the art and science of cytopathology. Chicago: American Society of Clinical Pathology Press, 1996; 207-56
32. Austin J, Cohen M. Value of having a cytopathologist present during percutaneous fine-needle aspiration biopsy of the lung: report of 55 cancer patients and meta-analysis of the literature. Am J Roentgenol 1993; 160:165-77
33. Coosemans W, Lerut T, Van Raemdonck D. Thoracoscopic surgery: the Belgian experience. Ann Thorac Surg 1993; 56: 621-60
34. Cummings S, Lillington G, Richard R. Estimating the probability of malignancy in solitary pulmonary nodules: a bayesian approach. Am Rev Respir Dis 1986; 134:449-52
35. Godwin JP, Speckman JM, Fram EK, et al. Distinguishing benign from malignant pulmonary nodules by computed tomography. Radiology 1982; 144:349-52
36. Harter LP, Moss AA, Goldberg HI, et al. CT-guided fine-needle aspirations for diagnosis of benign and malignant disease. Am J Roentgenol 1983; 140:363-67
37. Khouri NF, Stitik FP, Erozan YS, et al. Transthoracic needle aspiration of benign and malignant lung lesions. Am J Roentgenol 1985; 144:281-88
38. Lillington G, Cummings S. Decision analysis approaches in solitary pulmonary nodules. Semin Respir Med 1989; 10:227-31
39. Miller J. The present role and future considerations of video-assisted thorascopy in general thoracic surgery. Ann Thorac Surg 1993; 56:804-06
40. Warner K, Luce B. Cost-benefit and cost-effectiveness analysis in health care: principles, practice and potential. Ann Arbor, Mich: Health Administration Press, 1982
41. Cooper J. Perspectives on thoracoscopy in general thoracic surgery. Ann Thorac Surg 1993; 56:697-700
42. Kaiser L, Bavaria J. Complications of thoracoscopy. Ann Thorac Surg 1993; 56:796-98
43. Garland L. The rate and growth of natural duration of primary bronchial cancer. Am J Roentgenol Rad Ther Nucl Med 1966; 96:604-11
44. Nathan M, Colloing V, Adams R. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1962; 79:221-32
45. Nathan M. Management of solitary pulmonary nodules: an organized approach based on growth rate and statistics. JAMA 1974; 227:1141-44
46. Lipscomb J. Time preference for health in cost effectiveness analysis. Med Care 1989; 27(suppl 3):S233-52
47. Fox CR, Tversky A. Ambiguity aversion and comparative ignorance. Q J Econ 1995; 585-603
48. Hornberger J, Brown B, Halpern J. Designing a cost-effective clinical trial. Stat Med 1995; 14:2249-59